PPARA and metabolic dysfunction-associated steatotic liver disease: Acting as a partial agonist of peroxisome proliferator-activated receptor alpha (PPARα), a ligand-activated transcription factor associated with hepatic steatosis, silibinin protects against NAFLD in mice by reducing lipid accumulation.